EMAP
Grup d’Estudis de Medicament en Atenció Primària (EMAP)

RESPONSABLE DEL GRUP
40882722S - Rosa Morros Pedrós - OK retall
Rosa Morros Pedrós
rmorros@idiapjgol.org
avatar_grups_recerca.png

Publicacions

Linaclotide utilization and potential for off-label use and misuse in three European countries

J. CID-RUZAFA, B. LACY, A. SCHULTZE, M. DUONG, Y. LU, M. RALUY-CALLADO, R. DONALDSON, D. WEISSMAN, A. GOMEZ-LUMBRERAS, D. OUCHI, M. GINER-SORIANO, R. MORROS, A. UKAH and D. POHL
Therapeutic Advances in Gastroenterology. 2022 Jun 1; . doi:10.1177/17562848221100946; PMID:35706826

Health alliance for prudent prescribing and yield of antibiotics in a patient-centred perspective (HAPPY PATIENT): a before-and-after intervention and implementation study protocol

A. BJERRUM, A. GARCIA-SANGENIS, D. MODENA, G. CORDOBA, L. BJERRUM, A. CHALKIDOU, J. LYKKEGAARD, M. HANSEN, J. SONDERGAARD, J. NEXOE, I. REBNORD, I. SEBJORNSEN, J. JENSEN, M. HANSEN, K. TAXIS, M. LAMBERT, R. BENKO, B. LOPEZ-VALCARCEL, F. RAYNAL, N. BARRAGAN, P. TOUBOUL, P. BRUNO, R. RADZEVICIENE, L. JARUSEVICIENE, A. BANDZAITE, M. GODYCKI-CWIRKO, A. KOWALCZYK, C. LIONIS, M. KARKANA, M. ANASTASAKI, J. COLEMAN, H. GLASOVA, M. VAN AGTMAEL, P. TATTEVIN, A. BORRAS and C. LLOR
BMC Primary Care. 2022 May 2; . doi:10.1186/s12875-022-01710-1; PMID:35501712

Association between two mass-gathering outdoor events and incidence of SARS-CoV-2 infections during the fifth wave of COVID-19 in north-east Spain: A population-based control-matched analysis

C. SUNER, E. COMA, D. OUCHI, E. HERMOSILLA, B. BARO, M. RODRIGUEZ-ARIAS, J. PUIG, B. CLOTET, M. MEDINA and O. MITJA
Lancet Regional Health-Europe. 2022 Apr 1; . doi:10.1016/j.lanepe.2022.100337; PMID:35237763

Can routine Primary Care Records Help in Detecting Suicide Risk? A Population-Based Case-Control Study in Barcelona

M. FRADERA, D. OUCHI, O. PRAT, R. MORROS, C. MARTIN-FUMADO, D. PALAO, N. CARDONER, M. CAMPILLO, V. PEREZ-SOLA and C. PONTES
ARCHIVES OF SUICIDE RESEARCH. 2022 Jul 3; . doi:10.1080/13811118.2021.1911894; PMID:33896400

High-titre methylene blue-treated convalescent plasma as an early treatment for outpatients with COVID-19 a randomised, placebo-controlled trial

A. ALEMANY, P. MILLAT-MARTINEZ, M. CORBACHO-MONNE, P. MALCHAIR, D. OUCHI, A. RUIZ-COMELLAS, A. RAMIREZ-MORROS, J. CODINA, R. SIMON, S. VIDELA, G. COSTES, M. CAPDEVILA-JAUREGUI, P. TORRANO-SOLER, A. SAN JOSE, G. PAPELL, J. PUIG, A. OTERO, J. SUAREZ, A. PELLEJERO, F. ROCA, O. CORTEZ, V. GARCIA, J. VIDAL-ALABALL, A. MILLAN, E. CONTRERAS, J. GRIFOLS, A. ANCOCHEA, I. GALVAN-FEMENIA, F. FERREIRA, M. BONET, J. CANTONI, N. PRAT, J. ARA, A. ARCARONS, M. FARRE, E. PRADENAS, J. BLANCO, M. RODRIGUEZ-ARIAS, G. RIVAS, M. MARKS, Q. BASSAT, I. BLANCO, B. BARO, B. CLOTET and O. MITJA
Lancet Respiratory Medicine. 2022 Mar 1; . doi:10.1016/S2213-2600(21)00545-2; PMID:35150610

Patronat

Col·laboradors

Acreditacions